We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Tripos Announces Chemistry Collaboration with Abbott
News

Tripos Announces Chemistry Collaboration with Abbott

Tripos Announces Chemistry Collaboration with Abbott
News

Tripos Announces Chemistry Collaboration with Abbott

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tripos Announces Chemistry Collaboration with Abbott "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Tripos, Inc. has announced a chemistry collaboration with Abbott to design, synthesize and purify high-quality, novel, drug-like compounds to expand Abbott’s compound file collection. Tripos and Abbott will collaborate in library design, analysis and synthesis.

"The success of high-throughput technologies in pharmaceutical research is highly dependent on the close coupling of informatics and experimental science," said Dr. John P. McAlister, president and chief executive officer of Tripos.

"With its fully integrated, information-driven chemistry operations, including cutting-edge ChemCore™ and ChemSpace® technologies, Tripos is positioned to add value to the chemical libraries delivered to Abbott."

Advertisement